SID Type 2 Inflammation Innovation Award Application
Sanofi and Regeneron Pharmaceuticals-SID Type 2 Inflammation Grant Application
SID Type 2 Inflammation Innovation Awards are intended to support cutting-edge, innovative research projects being conducted by Early Stage/Young Investigators. The SID will convene an independent grant review committee to identify the awardees. Research must pertain to Type 2 immunity or diseases characterized by Type 2 inflammation including but not limited to: Atopic Dermatitis (or eczema), Chronic Urticaria, Allergic Contact Dermatitis, Prurigo Nodularis, Keloids, Systemic Scleroderma, Localized Scleroderma (or morphea), Hand and Foot Dermatitis, Bullous Pemphigoid and Alopecia Areata.
Please complete the application and upload the required documents.